Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Different hair loss types need accurate diagnosis for proper treatment.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Detailed history and physical examination are crucial for diagnosing hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Low iron and vitamin D levels are linked to hair loss in women.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

A new liposome treatment helps heal deep burns on mice by improving hair regrowth and reducing scarring.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.